113
Participants
Start Date
July 31, 2014
Primary Completion Date
December 31, 2016
Study Completion Date
June 30, 2017
MM-302
Gemcitabine
Capecitabine
Vinorelbine
Trastuzumab
Palo Verde Cancer Center, Glendale
Mayo Clinic Cancer Center, Scottsdale
University of Arizona Cancer Center, Tucson
St. Jude Heritage Healthcare, Fullerton
UC San Diego Moores Cancer Center, La Jolla
Ronald Reagan UCLA Medical Center, Los Angeles
Cancer Care Associates Medical Group, Redondo Beach
UCSF Medical Center, San Francisco
Sansum Clinic, Santa Barbara
Kaiser Permanent Medical Center, Vallejo
University of Colorado Cancer Center, Aurora
Rocky Mountain Cancer Centers, Littleton
Smilow Cancer Hospital at Yale New Haven Hospital, New Haven
Washington Cancer Institute, Washington D.C.
Florida Cancer Specialists & Research Institute, Fort Meyers
Memorial Regional Hospital, Hollywood
Mayo Clinic Cancer Center, Jacksonville
Sarah Cannon Research Institute, New Port Richey
UF Health Cancer Center at Orlando Health, Orlando
Florida Cancer Research Institute, Plantation
University of Miami Comprehensive Cancer Center, Plantation
Southeastern Regional Medical Center, Newnan
Northwestern University- Robert H. Lurie Comprehensive Cancer Center, Chicago
Rush University Medical Center, Chicago
University of Chicago, Chicago
Joliet Oncology-Hematology Associates, Joliet
Midwestern Regional Medical Center, Zion
Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
McFarland Clinic PC, Ames
Johns Hopkins Medicine- The Sidney Kimmel Comprehensive Cancer Center, Baltimore
Dana-Farber Cancer Institute, Boston
St. Joseph Mercy Hospital, Ann Arbor
University of Michigan Health System, Ann Arbor
Minnesota Oncology Hematology, Coon Rapids
University of Minnesota- Masonic Cancer Center, Minneapolis
Mayo Clinic Cancer Center, Rochester
Saint Luke's Hospital, Kansas City
Barnes-Jewish West County Hospital, St Louis
Hackensack University Medical Center, Hackensack
New Mexico Cancer Care Alliance, Albuquerque
New York Oncology Hematology, P.C., Albany
North Shore Hematology Oncology Associates, East Setauket
Morton Coleman MD, New York
NYU Langone Medical Center, New York
Montefiore Medical Center, The Bronx
Office of Carey K. Anders, Chapel Hill
Duke Cancer Institute, Durham
Oncology Hematology Care, Cincinnati
Cleveland Clinic, Cleveland
Ohio State University Hospital, Columbus
St. Charles Health System, Bend
Magee-Womens Hospital of UPMC, Pittsburgh
Bon Secours Saint Francis Hospital Cancer Center, Greenville
Greenville Health System Cancer Institute, Greenville
Tennessee Oncology, Chattanooga
The Sarah Cannon Research Institute, Nashville
Vanderbilt University Medical Center, Nashville
Texas Oncology- Central Austin Cancer Center, Austin
Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas
Texas Oncology- Medical City, Dallas
Texas Oncology, El Paso
The Center for Cancer and Blood Disorders, Fort Worth
Texas Oncology-Houston Memorial City, Houston
The University of Texas- MD Anderson Cancer Center, Houston
Cancer Care Centers of South Texas, San Antonio
Texas Oncology, Tyler
Huntsman Cancer Institute, Salt Lake City
Virginia Oncology Associate, Norfolk
Swedish Medical Center, Issaquah
Northwest Medical Specialties, Tacoma
Medizinische Universitat Innsbruck, Innsbruck
AKh Allgemeines Krankenhaus der Stadt Linz, Linz
Medical University of Vienna, Vienna
GZA Ziekenhuizen - Campus Sint-Augustinus, Antwerp
University Hospital Antwerp, Antwerp
Cliniques Universitaires Saint-Luc, Brussels
Clinique Saint-Joseph, Liège
London Regional Cancer Center, London
Sunnybrook Health Sciences Centre, Toronto
University of Alberta- Cross Cancer Institute, Edmonton
McGill University Health Center, Québec
Motol University Hospital, Prague
Institut de Cancerologie de l'Ouest site Paul Papin, Angers
Centre Léon Bérard, Lyon
Hopital de l'Institut Curie, Paris
Institut de Cancerologie de l'Ouest, Saint-Herblain
Institut Claudius Regaud, Toulouse
Universitatsklinikum des Saarlandes, Homburg
Universitätsklinikum Schleswig-Holstein, Lübeck
Interdisziplinares Onkologisches Zentrum, Munich
Istituto Clinico Humanitas, Rozzano
Centro Riferimento Oncologico, IRCCS, Istituto Nazionale Tumori, Aviano
Azienda Ospedaliero-Universitaria di Bologna, Bologna
Azienda Socio Sanitaria Territoriale di Cremona, Cremina
Oncology Unit Macerata Hospital, Macerata
Istituto Europeo di Oncologia, Milan
Istituto Nazionale Tumori, IRCCS Fondazione G. Pascale, Napoli
Instituto Oncologico Veneto IRCCS, Padua
Azienda Ospedaliero S. Maria di Terni, Terni
Hospital Universitario Vall d'Hebron, Barcelona
Hospital San Pedro de Alcantara, Cáceres
Hospital Universitario Reina Sofía, Córdoba
Hospital Universitario Arnau de Vilanova, Lleida
Hospital Clinico San Carlos, Madrid
Hospital General Universitario Gregorio Marañón, Madrid
Hospital Universitario Ramon y Cajal, Madrid
H.U.Son Espases, Palma de Mallorca
Hospital de Navarra, Pamplona
Hospital Universitario Virgen de la Macarena, Seville
Lead Sponsor
Merrimack Pharmaceuticals
INDUSTRY